Advances in Nano-Based Drug Delivery: Unveiling the Next Frontier

A special issue of Biomolecules (ISSN 2218-273X).

Deadline for manuscript submissions: 15 October 2024 | Viewed by 67

Special Issue Editors

Department of Chemical and Biological Engineering, The University of Alabama, Tuscaloosa, AL, USA
Interests: magnetic nanoparticles; imaging-guided drug delivery; MRI
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. Department of Chemical and Biomolecular Engineering, Clemson University, 105 Sikes Hall, Clemson, SC, USA
2. Department of Bioengineering, Clemson University, 105 Sikes Hall, Clemson, SC, USA
Interests: nanomedicine; drug delivery; brain disease; nerve regeneration; biomaterials; polymers
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Significant advancements in nano-based drug delivery systems have offered promising solutions to various challenges in drug delivery such as improved bioavailability, targeted delivery, and reduced side effects. This Special Issue aims to provide a comprehensive overview of the latest developments in this rapidly evolving field. This Special Issue welcomes key themes and contributions that include, but are not limited to, nanoformulations for targeted/precision therapy, controlled/on-demand smart drug delivery systems, nanoformulations for oral or topical delivery, nanosystems across biological barriers, biomimetic nanocarriers, and challenges and future perspectives. In summary, this Special Issue provides a valuable resource for researchers, clinicians, and industry professionals interested in the latest advances and future prospects of nano-based drug delivery systems. By highlighting cutting-edge research and addressing key challenges, it aims to catalyze further innovation in this rapidly expanding field, ultimately contributing to improved therapeutic outcomes for patients.

Dr. Yuping Bao
Dr. Jessica M. Larsen
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • targeted drug delivery
  • smart nanoformulation
  • controlled drug release
  • biocompatible nanocarriers
  • extracellular vesicles
  • immunotherapy

Published Papers

This special issue is now open for submission.
Back to TopTop